| Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors LG Buchynska, IP Nesina, NP Yurchenko, OO Bilyk, VN Grinkevych, ... Experimental oncology, 2007 | 64 | 2007 |
| Expression of the cell cycle regulators p53, p21 (WAF1/CIP1) and p16 (INK4a) in human endometrial adenocarcinoma. LG Buchynska, IP Nesina Experimental Oncology 28 (2), 152-155, 2006 | 34 | 2006 |
| Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers L Buchynska, N Iurchenko, V Grinkevych, I Nesina, S Chekhun, ... Experimental Oncology, 2009 | 32 | 2009 |
| Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1 M Mints, M Mushtaq, N Iurchenko, L Kovalevska, MC Stip, D Budnikova, ... Oncotarget 7 (16), 22150, 2016 | 30 | 2016 |
| Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia. LG Buchynska, IP Nesina, EV Kashuba Experimental oncology 29 (4), 287-294, 2007 | 27 | 2007 |
| Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia KEV Buchynska L.G., Nesina I.P. Experimental Oncology. 29 (4), 287-294, 2007 | 27 | 2007 |
| Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas LG Buchynska, OV Brieiev, NP Iurchenko Experimental Oncology 41 (2), 138-143, 2019 | 17 | 2019 |
| Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma IP esina, NP Iurchenko, LG Buchynska Experimental Oncology. 40 (3), 218–222, 2018 | 17 | 2018 |
| Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer NP Iurchenko, NM Glushchenko, LG Buchynska Experimental oncology, 262-266, 2014 | 15 | 2014 |
| FOXP3 gene promoter methylation in endometrial cancer cells LG Buchynska, NP Iurchenko, NP Verko, KA Nekrasov, VI Kashuba Experimental oncology, 246-249, 2015 | 13 | 2015 |
| Дослідження медикаментозної резистентності злоякісних новоутворень ендометрію залежно від агрегації пухлинної патології у родоводах хворих ЛГ Бучинська, ЛІ Воробйова, ІП Несіна Онкологія, 2005 | 10 | 2005 |
| Структурные аберрации хромосом в лимфоцитах периферической крови у больных предраком и раком эндометрия ПЛЗ Несина И.П. Цитология и генетика 29 (3), 17-24, 1995 | 10* | 1995 |
| Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium LG Buchynska, TV Borykun, NP Iurchenko, SV Nespryadko, IP Nesina Experimental Oncology 42 (4), 289-294, 2020 | 9 | 2020 |
| Assessment of DNA status and peculiarities of expression of cyclins D1 and transcription factor E2F1 in cells of epithelial endometrial tumors NP Iurchenko, NM Glushchenko, LG Buchynska Onkologiya 21, 230-7, 2019 | 8 | 2019 |
| Мorphological characteristics and expression of adhesion markers in cells of low differentiated endometrial carcinoma IPN L.G. Buchynska, L.А. Naleskina Experimental oncology 41 (4), 335–341., 2019 | 8 | 2019 |
| Phenotypic features of endometrial tumors in patients with family history of cancer LG Buchynska, NP Lurchenko, NM Glushchenko, IP Nesina Experimental Oncology 39 (4), 312–318., 2017 | 8 | 2017 |
| Molecular phenotype of high-grade endometrioid carcinoma of the endometrium LG Buchynska, NM Glushchenko, IP Nesina, OV Brieieva, NP Iurchenko Experimental oncology 42 (4), 300-305, 2020 | 7 | 2020 |
| Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12+-fibroblasts in endometrioid carcinoma of endometrium LG Buchynska, OM Movchan, NP Iurchenko Experimental Oncology 43 (2), 135-141, 2021 | 6 | 2021 |
| The study of chromosomal instability in patients with endometrial cancer INPNSVBLG Nesina I.P. Experimental Oncology 36 (3), 202-206, 2014 | 6 | 2014 |
| Цитологическая реактивность онкологического больного КП Ганина, ЛЗ Полищук, НВ Бородай, ЛА Налескина, ЛМ Исакова, ... К.: Наук. дум-.: Наук. дум-: Наук. думка, 1995 | 6 | 1995 |
